AZD2171: a highly potent, orally bioavailable, vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for the treatment of cancer (Q28251373)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
AZD2171: a highly potent, orally bioavailable, vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for the treatment of cancer
scientific article

    Statements

    AZD2171: a highly potent, orally bioavailable, vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for the treatment of cancer (English)
    0 references
    0 references
    Stephen R Wedge
    0 references
    Jane Kendrew
    0 references
    Laurent F Hennequin
    0 references
    Paula J Valentine
    0 references
    Simon T Barry
    0 references
    Sandra R Brave
    0 references
    Neil R Smith
    0 references
    Neil H James
    0 references
    Michael Dukes
    0 references
    Jon O Curwen
    0 references
    Rosemary Chester
    0 references
    Janet A Jackson
    0 references
    Sarah J Boffey
    0 references
    Lyndsey L Kilburn
    0 references
    Sharon Barnett
    0 references
    Graham H P Richmond
    0 references
    Peter F Wadsworth
    0 references
    Mike Walker
    0 references
    Alison L Bigley
    0 references
    Sian T Taylor
    0 references
    Lee Cooper
    0 references
    Sarah Beck
    0 references
    Juliane M Jürgensmeier
    0 references
    Donald J Ogilvie
    0 references
    15 May 2005
    0 references
    65
    0 references
    10
    0 references
    4389-400
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit